Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


05.03.2018

2 AJNR Am J Neuroradiol
3 BMC Cancer
1 Brain
2 Clin Cancer Res
1 Curr Treat Options Neurol
1 Eur J Cancer
3 Int J Radiat Oncol Biol Phys
1 J Neurochem
6 J Neurooncol
2 J Neurosurg
1 Neuro Oncol
1 Neurosurgery
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. SEN R, Sen C, Pack J, Block KT, et al
    Role of High-Resolution Dynamic Contrast-Enhanced MRI with Golden-Angle Radial Sparse Parallel Reconstruction to Identify the Normal Pituitary Gland in Patients with Macroadenomas.
    AJNR Am J Neuroradiol. 2017;38:1117-1121.
    PubMed     Text format     Abstract available

  2. XING Z, Yang X, She D, Lin Y, et al
    Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging.
    AJNR Am J Neuroradiol. 2017;38:1138-1144.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. TEYSSONNEAU D, Daste A, Dousset V, Hoepffner JL, et al
    Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
    BMC Cancer. 2017;17:323.
    PubMed     Text format     Abstract available

  4. SCHIMMEL WCM, Verhaak E, Hanssens PEJ, Gehring K, et al
    A randomised trial to compare cognitive outcome after gamma knife radiosurgery versus whole brain radiation therapy in patients with multiple brain metastases: research protocol CAR-study B.
    BMC Cancer. 2018;18:218.
    PubMed     Text format     Abstract available

  5. HAN Y, Yan LF, Wang XB, Sun YZ, et al
    Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
    BMC Cancer. 2018;18:215.
    PubMed     Text format     Abstract available


    Brain

  6. FERRUCCI V, de Antonellis P, Pennino FP, Asadzadeh F, et al
    Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-beta-OTX2-SNAIL via PTEN inhibition.
    Brain. 2018 Feb 27. pii: 4911167. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. SLANEY CY, von Scheidt B, Davenport AJ, Beavis PA, et al
    Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.
    Clin Cancer Res. 2017;23:2478-2490.
    PubMed     Text format     Abstract available

  8. GEOERGER B, Bourdeaut F, DuBois SG, Fischer M, et al
    A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors.
    Clin Cancer Res. 2017;23:2433-2441.
    PubMed     Text format     Abstract available


    Curr Treat Options Neurol

  9. IUS T, Cesselli D, Isola M, Toniato G, et al
    Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas.
    Curr Treat Options Neurol. 2018;20:3.
    PubMed     Text format     Abstract available


    Eur J Cancer

  10. LEVY A, Faivre-Finn C, Hasan B, De Maio E, et al
    Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.
    Eur J Cancer. 2018;93:37-46.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  11. CHEN L, Douglass J, Kleinberg L, Ye X, et al
    Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:916-925.
    PubMed     Text format     Abstract available

  12. MURPHY ES, Leyrer CM, Parsons M, Suh JH, et al
    Risk Factors for Malignant Transformation of Low-Grade Glioma.
    Int J Radiat Oncol Biol Phys. 2018;100:965-971.
    PubMed     Text format     Abstract available

  13. BOJAXHIU B, Ahlhelm F, Walser M, Placidi L, et al
    Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:987-996.
    PubMed     Text format     Abstract available


    J Neurochem

  14. HAPPOLD C, Stojcheva N, Silginer M, Weiss T, et al
    Transcriptional control of O(6) -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma.
    J Neurochem. 2018 Feb 26. doi: 10.1111/jnc.14326.
    PubMed     Text format     Abstract available


    J Neurooncol

  15. KIRCHES E, Steffen T, Waldt N, Hebert E, et al
    The expression of the MSC-marker CD73 and of NF2/Merlin are correlated in meningiomas.
    J Neurooncol. 2018 Feb 21. pii: 10.1007/s11060-018-2807.
    PubMed     Text format     Abstract available

  16. WASCHKE A, Arefian H, Walter J, Hartmann M, et al
    Cost-effectiveness of the long-term use of temozolomide for treating newly diagnosed glioblastoma in Germany.
    J Neurooncol. 2018 Feb 21. pii: 10.1007/s11060-018-2804.
    PubMed     Text format     Abstract available

  17. RODENBURG RJ, Hanssens PE, Ho VKY, Beerepoot LV, et al
    Validation of the Chowdhury overall survival score in patients with melanoma brain metastasis treated with Gamma Knife Radiosurgery.
    J Neurooncol. 2018 Feb 22. pii: 10.1007/s11060-018-2808.
    PubMed     Text format     Abstract available

  18. MALAKOOTIAN M, Mirzadeh Azad F, Fouani Y, Taheri Bajgan E, et al
    Anti-differentiation non-coding RNA, ANCR, is differentially expressed in different types of brain tumors.
    J Neurooncol. 2018 Feb 23. pii: 10.1007/s11060-018-2809.
    PubMed     Text format     Abstract available

  19. CHEN WC, Hara J, Magill ST, Wu A, et al
    Salvage therapy outcomes for atypical meningioma.
    J Neurooncol. 2018 Feb 26. pii: 10.1007/s11060-018-2813.
    PubMed     Text format     Abstract available

  20. DARLIX A, Griguolo G, Thezenas S, Kantelhardt E, et al
    Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
    J Neurooncol. 2018 Feb 27. pii: 10.1007/s11060-018-2805.
    PubMed     Text format     Abstract available


    J Neurosurg

  21. ROSSI M, Fornia L, Puglisi G, Leonetti A, et al
    Assessment of the praxis circuit in glioma surgery to reduce the incidence of postoperative and long-term apraxia: a new intraoperative test.
    J Neurosurg. 2018 Feb 23:1-11. doi: 10.3171/2017.7.JNS17357.
    PubMed     Text format     Abstract available

  22. WANG L, Chen W, Liu F, Zhang LF, et al
    Letter to the Editor. Multiple meningiomas.
    J Neurosurg. 2018 Feb 23:1-2. doi: 10.3171/2017.8.JNS172004.
    PubMed     Text format    


    Neuro Oncol

  23. OSTROM QT, Rubin JB, Lathia JD, Berens ME, et al
    Females have the survival advantage in glioblastoma.
    Neuro Oncol. 2018 Feb 21. pii: 4883496. doi: 10.1093.
    PubMed     Text format    


    Neurosurgery

  24. SENDERS JT, Muskens IS, Cote DJ, Goldhaber NH, et al
    Thirty-Day Outcomes After Craniotomy for Primary Malignant Brain Tumors: A National Surgical Quality Improvement Program Analysis.
    Neurosurgery. 2018 Feb 22. pii: 4898191. doi: 10.1093.
    PubMed     Text format     Abstract available


    Oncogene

  25. OYINLADE O, Wei S, Lal B, Laterra J, et al
    Targeting UDP-alpha-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration.
    Oncogene. 2018 Feb 26. pii: 10.1038/s41388-018-0138.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: